All News

OSSIO Receives FDA 510(k) Clearance for OSSIOfiber® Hammertoe Fixation System

March 12, 2020 WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, Inc., an orthopedic fixation company, today announced that its OSSIOfiber® Hammertoe Fixation System has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for maintenance of alignment and fixation of bone fractures, osteotomies, arthrodesis and bone grafts. These novel bio-integrative implants with disposable, sterile instrumentation now …

Centinel Spine Announces Steven F. Murray as CEO

NEW YORK, March 16, 2020 /PRNewswire/ — Centinel Spine®, LLC, the largest privately-held spine company focused on anterior column reconstruction, today announced Steven F. Murray as CEO effective March 16, 2020, succeeding the current Chairman & CEO John J. Viscogliosi, who is stepping down effective immediately to focus his efforts on further expanding Viscogliosi Brothers, LLC’s 20 years of leadership in the …

RTI Surgical Holdings, Inc.® to Delay Form 10-K filing for Fiscal Year 2019

DEERFIELD, Ill., March 16, 2020 (GLOBE NEWSWIRE) — RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, announced it will file a Form 12b-25 Notification of Late Filing with the Securities and Exchange Commission (the “SEC”) to provide a 15 calendar day extension within which to file its Form 10-K for the fiscal …

RSIP Vision Announces Breakthrough AI technology for 3D Reconstruction of Knees from X-ray Images

TEL AVIV, Israel, March 16, 2020 /PRNewswire/ — RSIP Vision, a global leader in artificial intelligence (AI) and computer vision technology, announced today a new innovative AI-based solution for 3D Reconstruction of Knees from X-ray Images. This technology provides physicians with a rich 3D modelling of each bone, which could provide critical data for surgery planning and …

​Nanostructured rubber-like material with optimal properties could replace human tissue

March 16, 2020 / Chalmers University of Technology Researchers from Chalmers University of Technology, Sweden, have created a new, rubber-like material with a unique set of properties, which could act as a replacement for human tissue in medical procedures. The material has the potential to make a big difference to many people’s lives. The research …

Hackensack University Medical Center is First in the Nation to Perform Total Knee Replacement with TSolution One® Total Knee Application by THINK Surgical Since FDA Clearance

HACKENSACK, N.J., March 16, 2020 /PRNewswire/ — Hackensack University Medical Center, a national leader in orthopedic care and robotic surgery, recently completed the first total knee replacement using the TSolution One® Total Knee Application. The system, which is manufactured by Fremont, California-based THINK Surgical, Inc., features an active robot for orthopedic surgery.  Hackensack Meridian Health is pleased to offer this advanced technology …

COVID-19: Orthopedic Surgeons SPEAK OUT

During these unsettling days, we at OrthoSpineNews would like to provide a space for surgeons and orthopedic industry representatives to share their experiences, concerns, and ideas. If you would like to participate, please leave a comment or contact Elizabeth Hofheinz at elizabeth@orthospinenews.com. April 9, 2020 From Kristy Weber, M.D., Chief of Orthopaedic Oncology at Penn …

Junctional Injuries On and Off the Battlefield

By Elizabeth Hofheinz, M.P.H., M.Ed., March 13, 2020 You don’t have to be in a war zone to experience a junctional injury, an event involving the … Oh no! It looks like you aren’t an OSN Premium Subscriber yet. Click here to sign up or login below. Username or E-mail Password Remember Me     …

Regeneron and Sanofi Begin Global Kevzara® (sarilumab) Clinical Trial Program in Patients with Severe COVID-19

TARRYTOWN, N.Y. and CAMBRIDGE, Mass., March 16, 2020 /PRNewswire/ — U.S. Phase 2/3 trial initiated and will begin enrolling patients immediately Regeneron is leading U.S. trials, Sanofi will lead upcoming ex-U.S. trials Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced they have started a clinical program evaluating Kevzara® (sarilumab) in patients hospitalized with severe COVID-19 infection. Kevzara is a fully-human monoclonal …

When will a coronavirus vaccine be ready?

Mon 16 Mar 2020 / Laura Spinney Even at their most effective – and draconian – containment strategies have only slowed the spread of the respiratory disease Covid-19. With the World Health Organization finally declaring a pandemic, all eyes have turned to the prospect of a vaccine, because only a vaccine can prevent people from getting sick. …

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1